NYSE: TEVA
Teva Pharmaceutical Industries Ltd Stock Ownership - Who owns Teva Pharmaceutical Industries?

Insider buying vs selling

Have Teva Pharmaceutical Industries Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Amir WeissChief Accounting Officer2025-12-1612,300$30.20
$371.51kSell
Roberto MignoneDirector2025-12-1677,400$30.24
$2.34MSell
Mark SabagSee Remarks2025-12-0998,168$28.70
$2.82MSell
Mark SabagSee Remarks2025-12-09118,724$28.75
$3.41MSell
Mark SabagSee Remarks2025-12-09118,724$18.61
$2.21MBuy
Richard DaniellExec. VP European Commercial2025-12-0915,011$16.99
$255.04kBuy
Richard DaniellExec. VP European Commercial2025-12-09115,468$28.68
$3.31MSell
Richard DaniellExec. VP European Commercial2025-12-09100,457$18.61
$1.87MBuy
Roberto MignoneDirector2025-11-2650,000$26.03
$1.30MSell
Christine FoxEVP Head of U.S. Commercial2025-11-2028,229$24.78
$699.51kSell

1 of 5

TEVA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TEVA insiders and whales buy or sell their stock.

TEVA Shareholders

What type of owners hold Teva Pharmaceutical Industries Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc5.07%58,302,688$1.98BInstitution
Harel Insurance Investments Financial Services Ltd3.91%44,951,773$1.53BInstitution
Phoenix Financial Ltd3.57%41,087,131$1.40BInstitution
Menora Mivtachim Holdings Ltd3.42%39,316,183$1.34BInstitution
Clal Insurance Enterprises Holdings Ltd3.25%37,404,106$1.27BInstitution
Migdal Insurance Financial Holdings Ltd3.25%37,402,212$1.27BInstitution
Norges Bank3.06%35,182,949$1.20BInstitution
Lingotto Investment Management LLP2.47%28,422,768$965.81MInstitution
Rubric Capital Management LP1.86%21,355,510$725.66MInstitution
State Street Corp1.51%17,348,809$589.51MInstitution

1 of 3

TEVA vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TEVA46.94%0.75%Net SellingNet Selling
HLN4.07%0.00%
ZTS77.61%6.11%Net SellingNet Selling
TAK4.10%0.00%
VTRS60.67%18.50%Net SellingNet Selling

Teva Pharmaceutical Industries Stock Ownership FAQ

Who owns Teva Pharmaceutical Industries?

Teva Pharmaceutical Industries (NYSE: TEVA) is owned by 46.94% institutional shareholders, 0.75% Teva Pharmaceutical Industries insiders, and 52.31% retail investors. Blackrock Inc is the largest individual Teva Pharmaceutical Industries shareholder, owning 58.30M shares representing 5.07% of the company. Blackrock Inc's Teva Pharmaceutical Industries shares are currently valued at $2.01B.

If you're new to stock investing, here's how to buy Teva Pharmaceutical Industries stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.